The Role of Corticosterone in the Early Response to Nevirapine Treatment in Mice: Implications for Idiosyncratic Drug-Induced Liver Injury
Year: 2024
Type: dissertation
Abstract: Idiosyncratic drug-induced liver injury (IDILI) is a potentially life-threatening adverse drug reaction, which has restricted the use of many drugs and even led to the withdrawal of some drugs from the market. Nevirapine, a non-nucleoside reverse transcriptase inhibitor used in the treatment of HIV/AIDS, is associated with idiosyncratic drug reactions (IDRs) such as IDILI and skin rash. Its usage has decreased due to these concerns, but it is still widely used in lower-resource settings. The mechanisms underlying IDRs are poorly understood, but most appear to be immune-mediated. There is very limited understanding of the early immune response following administration of drugs associated with IDRs, which likely occurs due to reactive metabolite formation. In this work, we aimed to characterize the links between covalent binding of nevirapine, the development of an early immune response, and the subsequent liver injury using a mouse model. We describe initial attempts to characterize an early immune response to nevirapine followed by the discovery that nevirapine induces the release of corticosterone. Corticosterone release is partially associated with the degree of drug covalent binding in the liver but is also likely mediated by other mechanisms at higher drug doses. Transcriptomic analysis confirms metabolic activation, glucocorticoid signaling, and decreased immune activation; we also found that GDF-15 warrants further investigation as part of the immune response to nevirapine. Finally, glucocorticoid blockade preceding the first dose of nevirapine attenuated nevirapine-induced liver injury at 3 weeks, suggesting that acute glucocorticoid signaling is harmful in the context of liver injury. Characterization of this early response is, therefore, demonstrated to be important in both understanding the pathophysiology underlying nevirapine-induced liver injury and in identifying means of preventing this liver injury. This understanding is necessary for the accurate prediction of a drug’s ability to cause IDRs and is therefore necessary for the safer design and use of medications.
Source: TSpace (University of Toronto)
Author: Jee, Alison
Institution: University of Toronto
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7132867381
